Corcept Therapeutics
CORT
#3248
Rank
$4.51 B
Marketcap
$42.49
Share price
1.21%
Change (1 day)
-49.30%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of December 2025 : $0.37 Billion USD

According to Corcept Therapeutics 's latest financial reports the company has $0.37 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31$0.37 B-2.92%
2024-12-31$0.38 B4.1%
2023-12-31$0.36 B-14.7%
2022-12-31$0.43 B93.11%
2021-12-31$0.22 B-49.28%
2020-12-31$0.44 B59.69%
2019-12-31$0.27 B33.47%
2018-12-31$0.20 B132.98%
2017-12-31$88.74 M72.2%
2016-12-31$51.53 M27.45%
2015-12-31$40.43 M66.76%
2014-12-31$24.24 M-55.81%
2013-12-31$54.87 M-41.01%
2012-12-31$93.03 M134.72%
2011-12-31$39.63 M61.26%
2010-12-31$24.57 M2.98%
2009-12-31$23.86 M30.36%
2008-12-31$18.3 M5.43%
2007-12-31$17.36 M83.65%
2006-12-31$9.45 M-67.48%
2005-12-31$29.08 M-22.25%
2004-12-31$37.4 M223.06%
2003-12-31$11.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
$20.10 B 5,301.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$11.53 B 2,999.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$13.59 B 3,553.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$7.26 B 1,852.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$14.56 B 3,813.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$10.67 B 2,767.91%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
$0.26 B-30.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$92.44 M-75.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$1.56 B 319.35%๐Ÿ‡บ๐Ÿ‡ธ USA